Drug class

Mast-Cell Stabilizer-Type Anti-allergy Systemic Agents

"Mast-Cell Stabilizer-Type Anti-allergy Systemic Agents" is a specialized formulary and clinical classification representing systemic formulations of mast-cell stabilizing pharmaceuticals, most notably oral cromolyn sodium. Read more about Mast-Cell Stabilizer-Type Anti-allergy Systemic Agents

8 drugs in this class 8 manufacturers

Advertisement

Drugs in Mast-Cell Stabilizer-Type Anti-allergy Systemic Agents

Showing 1–8 of 8 drugs

CROMOLYN SODIUM

MAST-CELL STABILIZER-TYPE ANTI-ALLERGY SYSTEMIC AGENTS · SYSTEMIC MASTOCYTOSIS
RISING PHARM

CROMOLYN SODIUM

PULMONARY MAST-CELL STABILIZER-TYPE ANTI-INFLAMMATORY AGENTS · SYSTEMIC MASTOCYTOSIS
MICRO LABS USA,

CROMOLYN SODIUM

PULMONARY MAST-CELL STABILIZER-TYPE ANTI-INFLAMMATORY AGENTS · MAINTENANCE THERAPY FOR ASTHMA
BRYANT RANCH PR

CROMOLYN SODIUM

PULMONARY MAST-CELL STABILIZER-TYPE ANTI-INFLAMMATORY AGENTS · MAINTENANCE THERAPY FOR ASTHMA
RITEDOSE PHARMA

CROMOLYN SODIUM

MAST-CELL STABILIZER-TYPE ANTI-ALLERGY SYSTEMIC AGENTS · SYSTEMIC MASTOCYTOSIS
OMNIVIUM PHARMA

CROMOLYN SODIUM

MAST-CELL STABILIZER-TYPE ANTI-ALLERGY SYSTEMIC AGENTS · SYSTEMIC MASTOCYTOSIS
WALLACE/MYLAN
Filter & compare in the drug finder → Opens the drug finder with Mast-Cell Stabilizer-Type Anti-allergy Systemic Agents preselected. Add indication or manufacturer filters there.

About Mast-Cell Stabilizer-Type Anti-allergy Systemic Agents.

"Mast-Cell Stabilizer-Type Anti-allergy Systemic Agents" is a specialized formulary and clinical classification representing systemic formulations of mast-cell stabilizing pharmaceuticals, most notably oral cromolyn sodium.

These agents function primarily by preventing antigen-induced degranulation of sensitized mast cells, thereby blocking the downstream release of potent inflammatory and allergic mediators, including histamine and leukotrienes.

Clinically, these systemic agents are primarily indicated for the management of systemic mastocytosis and other mast cell activation disorders to control gastrointestinal and systemic symptoms, as well as adjunctive long-term prophylaxis in severe refractory allergic conditions.